GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medeon Biodesign Inc (ROCO:6499) » Definitions » Market Cap

Medeon Biodesign (ROCO:6499) Market Cap : NT$4,026.7 Mil (As of Apr. 02, 2025)


View and export this data going back to 2014. Start your Free Trial

What is Medeon Biodesign Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Medeon Biodesign's share price for the quarter that ended in Dec. 2024 was NT$39.65. Medeon Biodesign's Shares Outstanding (EOP) for the quarter that ended in Dec. 2024 was 92.1 Mil. Therefore, Medeon Biodesign's market cap for the quarter that ended in Dec. 2024 was NT$3,653.5 Mil.

Medeon Biodesign's quarterly market cap declined from Jun. 2024 (NT$4,699.3 Mil) to Sep. 2024 (NT$4,261.7 Mil) and declined from Sep. 2024 (NT$4,261.7 Mil) to Dec. 2024 (NT$3,653.5 Mil).

Medeon Biodesign's annual market cap declined from Dec. 2022 (NT$5,091.6 Mil) to Dec. 2023 (NT$4,293.7 Mil) and declined from Dec. 2023 (NT$4,293.7 Mil) to Dec. 2024 (NT$3,653.5 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Medeon Biodesign's Enterprise Value for Today is NT$3,003.6 Mil.


Medeon Biodesign Market Cap Historical Data

The historical data trend for Medeon Biodesign's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medeon Biodesign Market Cap Chart

Medeon Biodesign Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3,642.63 6,601.90 5,091.64 4,293.71 3,653.51

Medeon Biodesign Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4,293.71 3,985.23 4,699.34 4,261.66 3,653.51

Competitive Comparison of Medeon Biodesign's Market Cap

For the Medical Instruments & Supplies subindustry, Medeon Biodesign's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medeon Biodesign's Market Cap Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medeon Biodesign's Market Cap distribution charts can be found below:

* The bar in red indicates where Medeon Biodesign's Market Cap falls into.


;
;

Medeon Biodesign Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Medeon Biodesign's Market Cap for the fiscal year that ended in Dec. 2024 is calculated as

Market Cap (A: Dec. 2024 )=Share Price (A: Dec. 2024 )*Shares Outstanding (EOP) (A: Dec. 2024 )
=NT$39.65*92.144
=NT$3,653.5

Medeon Biodesign's Market Cap for the quarter that ended in Dec. 2024 is calculated as

Market Cap (Q: Dec. 2024 )=Share Price (Q: Dec. 2024 )*Shares Outstanding (EOP) (Q: Dec. 2024 )
=NT$39.65*92.144
=NT$3,653.5

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medeon Biodesign  (ROCO:6499) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Medeon Biodesign Market Cap Related Terms

Thank you for viewing the detailed overview of Medeon Biodesign's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Medeon Biodesign Business Description

Traded in Other Exchanges
N/A
Address
No. 116, HouGang Street, 7th Floor, Shilin District, Taipei, TWN, 11170
Medeon Biodesign Inc develops medical device products. The main services of the Group are the research and development of medical devices, manufacturing, and sale of injection molding and components of medical devices. The company provides products in the fields of cardiovascular and laparoscopic. Its business includes Medical Device Development Department and Medical Device Components Manufacturing and Sales Department. The majority of the company revenue comes from Medical Device Components Manufacturing and Sales Department segment. The company revenue is mainly derived from the USA.

Medeon Biodesign Headlines

No Headlines